[1] |
裴仁治, 斯婷, 陆滢, 等. 高危急性早幼粒细胞白血病临床特征及预后分析[J]. 中华血液学杂志, 2016,37(5):360-365.
|
[2] |
CHAMOUN K, KANTARJIAN H M WANG X, et al. Unrecognized fluid overload during induction therapy increases morbidity in patients with acute promyelocytic leukemia[J]. Cancer, 2019,125(18):3219-3224.
DOI
URL
|
[3] |
HU J, SUN Q, FANG W, et al. Effect of combination of all-trans retinoic acid and arsenic trioxide on apoptosis of acute promyelocytic leukemia cells[J]. Cell Mol Biol(Noisy-le-grand), 2019,65(4):97-100.
|
[4] |
NØRGAARD J M, FRIIS L S, KRISTENSEN J S, et al. Addressing the room for improvement in management of acute promyelocytic leukemia[J]. Eur J Haematol, 2019,102(6):479-485.
DOI
URL
PMID
|
[5] |
中华医学会血液学分会. 急性早幼粒细胞白血病中国诊疗指南(2011年版)[J]. 中华血液学杂志, 2011,32(12):885-886.
|
[6] |
SANZ M A, COCO F L MARTÍN G, et al. Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia:a joint study of the PETHEMA and GIMEMA cooperative groups[J]. Blood, 2000,96(4):1247-1253.
URL
PMID
|
[7] |
LOU Y, MA Y, SUN J, et al. Effectivity of a modified Sanz risk model for early death prediction in patients with newly diagnosed acute promyelocytic leukemia[J]. Ann Hematol, 2017,96(11):1793-1800.
URL
PMID
|
[8] |
方力维, 秦铁军, 徐泽锋, 等. 急性早幼粒细胞白血病患者早期死亡及生存影响因素分析[J]. 中国实验血液学杂志, 2018,26(1):52-57.
|
[9] |
ONO T, TAKESHITA A, KISHIMOTO Y, et al. Expression of CD56 is an unfavorable prognostic factor for acute promyelocytic leukemia with higher initial white blood cell counts[J]. Cancer Sci, 2014,105(1):97-104.
DOI
URL
PMID
|
[10] |
WU H, LIU J, HUANG X, et al. RACK1 deficiency synergizes with all-trans retinoic acid to induce apoptosis in human acute promyelocytic leukemia cells[J]. Mol Cell Biochem, 2019,451(1-2):155-163.
DOI
URL
PMID
|
[11] |
LENGFELDER E, HANFSTEIN B, HAFERLACH C, et al. Outcome of elderly patients with acute promyelocytic leukemia:results of the German Acute Myeloid Leukemia Cooperative Group[J]. Ann Hematol, 2013,92(1):41-52.
URL
PMID
|
[12] |
MONTESINOS P, BERGUA J M, VELLENGA E, et al. Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy:characteristics,outcome,and prognostic factors[J]. Blood, 2009,113(4):775-783.
URL
PMID
|
[13] |
PARK S, LEE S J, KIM K, et al. Inclusion of hemoglobin level in prognostic score provides better prognostic stratification in patients with acute promyelocytic leukemia(APL)[J]. Int J Hematol, 2013,97(3):388-396.
DOI
URL
PMID
|